It is salutary to reflect that programmed cell ceath (PCD) was first defined as a morphogenetic process over 30 years ago, and apoptosis was defined as a non-inflammatory mechanism for the removal of single cells from complex organs nearly 25 years ago. For many years, these remained essentially descriptive phenomena, and it was not until the recognition of similar processes in C. elegans, the identification of those genes regulating nematode apoptosis and the realization that these nematode genes have mammalian homologues, that the field began to expand exponentially. We have asked Andrew Wyllie, John Kerr and Richard Lockshin, some of the pioneers of apoptosis to review the scientific progress of apoptosis. The comments of Richard Lockshin (1997) accompany this paper.
Until recently, apoptosis (ap-o È p-to È`sis; from the greek apo, off + ptosis, a falling or dropping off) was not listed in major dictionaries. It is now defined as`a single deletion of scattered cells by fragmentation into membrane-bound particles which are phagocytosed by other cells; believed to be due to programmed cell death ' (Stedman's Medical Dictionary, 1995) . As PCD/apoptosis emerged as a scientific field in its own right, it became apparent that no existing journal catered specifically to the increasingly varied aspects of the new discipline. Cell Death and Differentiation was launched in 1994 to provide a forum dedicated to this topic, accomodating the expansion of the field. In recognition of the linkage between suicidal, proliferative and differentiative decisions, the journal retains`differentiation' in its title.
The definition, as well as the importance of apoptosis, is evident to the readers of Cell Death and Differentiation. Cell death, along with differentiation and growth, is a fundamental aspect of the life cycle of a eukaryotic cell; the control of cell number is the result of the balance between cell loss and gain. The molecular mechanisms leading to the controlled removal of cells in tissues by apoptosis are not fully understood. It is clear that under physiological conditions the process is active, requires energy and the induction/activation of specific genes Arends and Wyllie, 1991; Schwartz, 1995; Zakeri et al, 1995; Peter et al, 1996) . Genetic studies in the nematode C. elegans (Ellis and Horvitz, 1986; Ellis et al, 1991) have led to the identification of several genes needed for the completion of the cell death program. These genes have been classified into specific functional groups that play distinct roles within the cell death program. The first group of genes includes permissive elements which specify which cells will undergo apoptosis. The second group comprises elements whose induction or down-regulation initiates the apoptosis pathway. A third set of genes includes effector elements required for killing and the subsequent disposal and degradation of cellular remnants. Genes with functional homology to some of those defined in C. elegans have been described in mammals: Bcl-2 and ced-9, caspases and ced-3. These genes, grown into families of homologous genes, together with additional important regulatory elements, are at the center of intense research efforts to dissect the molecular mechanisms of the death machinery.
Becoming more involved in the dissemination of scientific results, rather than in their creation, inevitably leads to a different perspective on science. The scientific paper is the medium for scientists to communicate their ideas and claims to new knowledge; citations of papers acknowledge the existence of these claims. Therefore, by aggregating citations, bibliometrics aggregates commentaries on early papers providing a means for examining consensus in a field of science. Bibliometric tools can be applied to understand the development of new research fields. The resources at the Institute for Scientific Information (ISI) allow for such a detailed analysis of the development of any scientific area by studying the appearance, frequency, citation and co-citation of papers published in that area. In this paper we present the results of a bibliometric study of apoptosis. These data should complement the more traditional historical scientific review by Richard Lockshin (1997, this issue) . We invite readers to compare the two approaches for their similarities (and differences).
The primary database used in this study was the ISIindicators file for 1981 ± 1995. In addition, the Science Citation Index on CD-ROM and the SCI-Search Dialog file were used as well as ISI's Inventory of Research Fronts.
PCD is a rapidly expanding ®eld
Apoptosis is a field which was identified in 1965 ± 1970 through the pioneering work of a long list of eminent scientists. Although cell death was recognized as early as 1899 by Terre (see Lockshin, 1997 , this issue of Cell Death and Differentiation), this concept remained preliminary and cryptic until the 1960s. For example, the notable paper by Saunders in 1948 (which was cited 459 times before 1992, becoming a`citation classic', and by now has nearly 550 citations) describes the effect of`necrosis of the mesodermal cells in the apex of the [chick wing] bud' with`a rather pronounced contraction or shrinkage of the wing mesoblast'. In fact, the description of this effect of cell death is not fully clear and the author concludes that`the significance of these results is thus far rather obscure '. Around 1965 , Saunders (1966 , Tata (1966) and Lockshin and Williams (1964, 1965a and b) defined the process in insects and the latter author used the term Programmed Cell Death' for the first time. In 1972, Kerr, Wyllie and Currie introduced its role in histopathology and cancer with the name`Apoptosis'. It was not until 1980 that a turning point in the study of apoptosis occurred, when the biochemical methods (DNA fragmentation; Wyllie et al, 1980a, b) which supported its morphological characteristics were identified (Bowen and Lockshin, 1981) . Later, in the mid 1980s, Horvitz (Sulston and Horvitz, 1977; Horvitz et al, 1983; Ellis and Horvitz, 1986; Ellis et al, 1991; Hengartner et al, 1992) outlined a series of genes related to PCD in C. elegans. Around 1991 the molecular mechanism begun to be understood with the identification of the role of CD95 (APO-1/Fas) Itoh et al, 1991) , Bcl-2 , p53 , and c-myc (Evan et al, 1992) . After 1991, the field had evidently become widely recognized. Consequently, the number of papers published increased to the present level of 5,000 per year.
Between 1980 ± 1996 at least 20,000 papers were published on cell death. It compares in size to other new fields, such as nitric oxide (NO), with 30,000 papers, and p53, with 17,500 papers. However, while these two other fields developed rapidly immediately after their identification, PCD started in 1960 with a long lag phase of only about 100 papers per year; then, from 1991 onward, the number of papers published each year exploded. Figure 1 shows the annual output of papers published on apoptosis since 1970.
Increasing impact of PCD papers
The exponential growth in the number of papers published since 1990 has been accompanied by an increase in citation impact. In fact, the average number of citations per paper rose from four to 14. Figure 2 shows the pattern of mean citationper-paper distribution over 5-year windows. The 5,900 papers published between 1981 ± 1996 on cell death/apoptosis (listed in the title) received 80,000 citations, with a mean of 13.5 citations per paper. Two observations are noteworthy: first, average citations have risen from circa 3.5 ± 4 to over 13.5 over the last decade, showing a significant increase in impact; and second, there is a certain level of uncitedness. The 13.5 mean citations arises from the group of highly cited papers. Of these 5,927 published papers, 2,870 were never cited, 538 were cited only once and 290 were cited twice. That is, over 62% of published papers received less than two citations.
PCD is now one of the hottest areas of science. In fact, among the 10 most-cited scientific papers published in 1995 and cited in 1995, four concern PCD: (4th) Dhein J et al (1995) , (55 cites); (5th) Brunner T et al (1995) 
Late recognition effect
The citation analysis literature provides only a few documented examples of delayed recognition. In the early 70s the classic paper by Kerr et al (1972) was cited in less than 20 papers per year. Twenty years later, by 1991, it had been cited in more than 400 publications. In 1995 alone it was cited over 400 times. Figure 3 shows the number of citations recorded for some early relevant papers published on PCD. The paper by Kerr et al, 1972 (bold line) shows the strongest`delayed recognition effect'. Figure 3 shows two different trends. While other papers on human pathology and cancer show the same effect to a lesser degree, the early papers on insect models did not show this delayed recognition effect. This might be due to the smaller scientific community studying these models. 
Areas of interests and country origins of papers
The major areas in which PCD papers are published are cancer, immunology, AIDS, embryology, development, pathology, pharmacology and toxicology. These data are reported in Figure 4 .
In order to evaluate certain differences in the field, we have divided the papers published into early period (1972 ± 1987; 1,146 papers) and late period (1995 ± 1996; 9,722 papers) papers. The middle period (1988 ± 1994) shows an intermediate pattern (data not shown).
As shown in Figure 5 , both early and late papers came predominantly from Europe and North America, although Australia was significant in the early years. Today relatively few papers come from the rest of the world. Table 1 ranks the journals publishing papers on PCD by frequency. The data have been divided into early (panel A, 1972 ± 1987; 1,146) and late (panel B, 1995 ± 1996; 9,722) papers. No one journal collects more than 3% of the papers. Figure 3 Late recognition effect of some early papers on Cell Death. The paper by Kerr et al. 1992 shows the most striking delayed recognition effect Figure 4 Areas of interest. The papers published in the period 1981 ± 1995 were classified by area of interest. Some papers have been assigned to more than one field Early (1972 ± 1987) PCD papers were published predominantly in pathology or anatomical journals with lower impact factors. Late (1995 Late ( ± 1996 papers appeared in basic science and immunology journals.
Distribution of papers in different journals
More recently, PCD papers have begun to appear in clinical journals. Publications have shifted from pathology studies into basic research, followed by pharmacological and clinical studies, thereby reflecting the maturation of the field.
The most cited
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Co-citation analysis involves the application of clustering and scaling methods to data on the number of times earlier papers are cited together by later papers. The building of nested sets of clusters allows us to view science with various degrees of resolution, from narrowly focused problem areas to entire disciplines, from cross-sectional representations to longitudinal changes in order to obtain patterns of continuity. For several decades, ISI has identified Research Fronts using the method of co-citation analysis (Small, 1994; Small and Citations were counted up to October 1996 from the SCI database on Cell-Death and Apoptosis (1980 ± 1995; 5,927 items) . *=Rank using as title's keyword Cell-Death (CD) or apoptosis (A). **=Citations were retrieved from the main SCI database; since these items are too old, before the existing SCI database, the papers were selected on an empirical anecdotal base, without the use of algorithms. Greenlee, 1995) . The algorithm clusters papers on the basis of variable thresholds of co-citation, thereby grouping papers that are frequently cited together by other authors. From the 600,000 papers published each year, about 10,000 Research Fronts will be identified. Each of these will consist of two to 50 core cited papers as well as the variable number of citing papers each year. The average annual cluster will contain about 40 citing (current) papers. It is a purely computational procedure based on citation links and is, in fact, a means of automatic classification. Clusters vary from a small group of papers up to thousands defining a discipline. The first SCI Research Front on PCD identified emerged in 1984, several years after the initial papers were published. This research front consisted of three co-sited core documents, each of which was cited separately, as shown: In the following years, PCD continued to appear on only one research front. The subsequent proliferation of PCD research can be seen in the increased number of clusters and the number of core documents (data not shown). In 1991 ± 1992, the field expanded dramatically and began a process of`twigging', or the splitting off and proliferation of research areas that develop in parallel. This indicates the growth and the progression of PCD research through the cluster-level hierarchy. In fact, by 1994, the number of Research Fronts had expanded to 17 (Figure 6 ), indicating the ongoing evolution of PCD as a research field. Figure 6 reports the Research Fronts identified until 1992 and 1994 (the last years to be evaluated since the analysis was performed in alternate years this decade). The cluster strings show an interesting pattern, corresponding either to models (prostate, thymus, nervous system), or molecules (Bcl-2, CD95). It is evident that the area of PCD is subdividing into divergent fields. The character of the research has also changed from descriptive morphological studies to the analysis of the molecular mechanisms involved, and it is becoming clear that the clinical implications are opening therapeutic applications (Knight, 1995; Gougeon, 1995; Ameisen et al, 1995; Wyllie, 1996; Krammer, 1996 Krammer, , 1997 .
In order to evaluate the relationship between different research sub-areas, cluster maps can be created using multidimensional scaling. This algorithm uses a measure of association among objects as input, normalized co-citation links, producing a spatial representation of those objects in Citations were counted up to Ocotober 1996 from the SCI database on CellDeath and Apoptosis (1980 ± 1995; 5,927 items) . Only authors with more than 10 papers were included. Citations were counted up to October 1996 from the SCI database on Cell-Death and Apoptosis (1980 ± 1995; 5,927 items) . a specified number of dimensions (two in this case) but multidimensional in the case of experimental prototype maps. These representations are referred to as`maps of science' since they describe the relationship between papers, fields or areas, and therefore between scientific ideas. SCI-Map is a ISI PC program running under Microsoft Windows; it takes input data on nodes and links, creating clusters node by node on screen, forming a network. In this case, nodes are papers, and links must have numerical similarity values ranging from zero to one, the inter-node distances are computed by a logarithmic transformation of the similarity values. The document is base on geometric triangulation (rather than other more mathematically based mapping methods) of the strongest interdocument links, in an attempt to represent intrinsic associations among items. We select a starting document or`seed' node and then add nodes one by one (according to qualifying, ordering and inclusion rules) which are displayed on the screen with their links as they are added. The seed paper affects the geometry of the cluster formed and the order in which nodes are added, similarly to the chaos theory. Figure 7 is a`SCI-Map' showing the co-citation relationship of several early papers on PCD. This is a lower-level map with only a few papers to show the early aggregations to the seed paper. The SCI-Map started with a seed paper (Wyllie et al, 1980b) from which the computer algorithm identified the closest papers in term of co-citations. Each circle represents one paper and the length of the connecting string is proportional to co-citations found in the papers, indicating the`similarity' of the papers. Interestingly, the results show (i) another paper (Kerr et al, 1972) with which it co-defines the Research Fronts in 1984 Fronts in , 1985 Fronts in , 1986 Fronts in , 1987 Fronts in , 1989  (ii) two papers (Wyllie et al, 1980a; Cohen and Duke, 1984) from the 1986 and 1989 Research Front; (iii) three papers (Duke, 1983; Duvall, 1986; Smith et al, 1989 ) from the 1989 Research Front. These close connections show how strongly related the papers forming the early Research Fronts are; these papers led to the first clear identification of the field.
Finances
The increased interest in cell death has affected the research funding system both at public and private levels. In fact, the National Institutes of Health funding of extramural grants on cell death has more than doubled each year since 1992, when 78 projects were funded with 12 million dollars (Lewis, 1995) . A similar trend has been observed for the European Union. Similarly, pharmaceutical and biotechnology industries have invested more and more resources for studies on cell death.
In In addition to these companies, others have also developed interests directed at apoptosis. The results of the analysis depend on the correct choice of a keyword. For example, the analysis published in The Scientist (Lewis, 1995) reported a list of the most-cited papers in the field:
Searching for`apoptosis' skews the results towards (i) European authors, and (ii) immunologists. In fact, neurologists and embryologists tend to favor the term`programmed cell death'. Similarly, using`apoptosis' alone as a title-keyword search in the SCI-database, the authors of the above analysis (Lewis, 1995) found that eight out of ten top papers were authored by Europeans. This does not mean that most of the important science has been done in Europe, but merely that Europeans used the word apoptosis' more often in the titles of their papers. Other highly respected scientists were not included, simply because they used the term`cell death' in their papers, and were thus not retrieved. In fact Table 2B shows the rank each paper would have had searching only with the title's keyword Cell-Death (Rank-CD*) or Apoptosis (Rank-A*). The two lists are clearly different, as US authors tended to use the word Cell-Death rather than apoptosis, at least during the earlier years.
To correct that situation we used both terms in the analysis in Table 2 , showing the ranking of the most cited papers in 1960 ± 1980 (Table 2A) , in 1981 ± 1993 (Table  2B ), in 1994 (Table 2C) , and in 1995 (Table 2D) .
Most analyses performed in this report used the term Apopt(free ending)' and/or`(free) Cell (free ending) Death', unless otherwise stated. These terms were searched in the title and keywords, unless otherwise stated.
A cautionary tale
We report the bibliometric evaluation of the field of cell death over the last 3 decades, with the more recent pattern of subdivision. Our data demonstrate the use of the Science Citation Index in evaluating various facets of a scientific topic. The same methodology can be applied to any area of science to elucidate development and other patterns of interest to scientists, publishers and historians. What is the significance of the merging and splitting patterns in the course of development of PCD research? Can cluster proximity on higher-level maps forecast a merger and synthesis of areas later on? Can maps be used to suggest hypotheses that scientists could fruitfully explore at the experimental level? Will a breakthrough come from within the field itself or from some seemingly unrelated or fringe territory of research? As described by Small (1994) , bibliometrics never claimed to offer insights into scientific knowledge, but the tools of bibliometrics can in fact be put at the service of advancing scientific knowledge in actual practice.
The complexity of the growth of PCD may be highlighted not only by the presence of multiple highly complex molecular mechanisms (transcription factors, effectors, receptors, binding proteins, degrading enzymes), but also by the concomitant presence of methodological progress (morphology, DNA ladder) and models (insects, cancer, C. elegans, thymus, prostate). The result of all this work will increase the understanding of the field.
Cell death by apoptosis is currently thought to consist of several convergent step-by-step regulated processes which are reversible until a late common execution stage. In fact, it is now clear that many agents are able to induce apoptosis in different cell types and under various physiological or experimental circumstances. Thus, it is reasonable to expect that the expression of the putative apoptotic genes should be controlled by multifunctional promoters; future studies will certainly lead to the identification of unknown regulatory steps which are very likely related to new biological functions and which may represent target points for the control of the death program with obvious therapeutic implications. In conclusion, although many aspects of the biology of PCD remain speculative, clarification of the mechanisms by which different factors control cell surival and cell death will lead to the understanding of many diseases that affect growth and degeneration. Early clinical studies seem to promise new pharmaceutical developments.
Martin Raff (1996) brings the serious philosophical problem hunted by Albert Camus and Jean Paul Sartre, that is suicide . . ., to a microscopic scale. To what extent is cell suicide an individual decision and to what degree a social one? To what extent is cell death balancing cell growth? Is necrosis`dead'? When talking of cell death, we have to be careful not to lurch from one fashionable extreme to the other. Perhaps because of the frequency and therapeutic intractability of human cancer, more emphasis has been laid on cell proliferation and its control than on cell death and differentiation. Now, it seems, the perspective favours death, and pathological proliferation is regarded as inappropriate evasion of physiological death. A growth factor is now an anti-death factor. Death is the default option for the cell. And so on and so on. Perhaps, indeed, we have subconsciously excluded`proliferation' from the title of Cell Death and Differentiation for these reasons, too.
